The reported differences in the intrathecal EBV-specific CD8 T cell response between MS patients and patients with other inflammatory neurological diseases indicate that accumulation of EBV-specific CD8 T cells in the CSF during MS results from an antigen-driven pathologic process and is not the consequence of non-specific recruitment due to ongoing CNS inflammation. This evidence concerns the gene CD8A and myeloid sarcoma.